H19 and Ehlers-Danlos syndrome, musculocontractural type: These results provide evidence that H19 was upregulated in ATC, and H19 siRNA (shRNA) has on-target effects and thus validates that H19 has an important role in both antitumor and antimetastatic role and may be a potential therapeutic target for the treatment of ATCs.